Description
Hanke objektiks on ravimid toimeainetega bevatsizumab, nab-paklitakseel, totsilizumab, trastuzumab, rituksimab ja infliksimab. Hankes osaleb Tervisekassa koos HVA haiglatega. / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
L01FG01, Bevatsizumab, infusioonilahuse kontsentraat biooriginaal, 100 mg / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest; L01FG01, Bevatsizumab, infusioonilahuse kontsentraat biooriginaal, 400 mg / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 weeks ago
More from this buyer
Full buyer profileRecent awards
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,651,178
- Buyer track record on Aperlena
- 3 notices tracked · 3 awarded
- €17,440,308 in awarded contracts
Never miss a tender like this
28 new notices in Medical equipment & pharmaceuticals in Estonia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert